Mizuho Medy Co Ltd
TSE:4595

Watchlist Manager
Mizuho Medy Co Ltd Logo
Mizuho Medy Co Ltd
TSE:4595
Watchlist
Price: 2 289 JPY -0.82% Market Closed
Market Cap: 34.4B JPY
Have any thoughts about
Mizuho Medy Co Ltd?
Write Note

Mizuho Medy Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mizuho Medy Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Mizuho Medy Co Ltd
TSE:4595
Retained Earnings
ÂĄ15.4B
CAGR 3-Years
33%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Terumo Corp
TSE:4543
Retained Earnings
ÂĄ1T
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
10%
Olympus Corp
TSE:7733
Retained Earnings
ÂĄ409.9B
CAGR 3-Years
27%
CAGR 5-Years
12%
CAGR 10-Years
12%
Sysmex Corp
TSE:6869
Retained Earnings
ÂĄ384.6B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
12%
Nihon Kohden Corp
TSE:6849
Retained Earnings
ÂĄ161.7B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
9%
JEOL Ltd
TSE:6951
Retained Earnings
ÂĄ80.7B
CAGR 3-Years
35%
CAGR 5-Years
28%
CAGR 10-Years
29%
No Stocks Found

Mizuho Medy Co Ltd
Glance View

Market Cap
34.4B JPY
Industry
Health Care

Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Intrinsic Value
2 410.26 JPY
Undervaluation 5%
Intrinsic Value
Price

See Also

What is Mizuho Medy Co Ltd's Retained Earnings?
Retained Earnings
15.4B JPY

Based on the financial report for Sep 30, 2024, Mizuho Medy Co Ltd's Retained Earnings amounts to 15.4B JPY.

What is Mizuho Medy Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
43%

Over the last year, the Retained Earnings growth was 10%. The average annual Retained Earnings growth rates for Mizuho Medy Co Ltd have been 33% over the past three years , 43% over the past five years .

Back to Top